These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25842964)

  • 1. Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).
    Kane CD; Nuss JE; Bavari S
    Expert Opin Ther Pat; 2015 Jun; 25(6):675-90. PubMed ID: 25842964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of Botulinum Neurotoxins for Biomedical Applications.
    Webb RP
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29882791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.
    Chen S
    Toxins (Basel); 2012 Oct; 4(10):913-39. PubMed ID: 23162705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and future directions of botulinum neurotoxins for targeting pain processing.
    Pellett S; Yaksh TL; Ramachandran R
    Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in searching for therapeutics against Botulinum Neurotoxins.
    Pirazzini M; Rossetto O
    Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.
    Chen JJ; Dashtipour K
    Pharmacotherapy; 2013 Mar; 33(3):304-18. PubMed ID: 23400888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Expanding Therapeutic Utility of Botulinum Neurotoxins.
    Fonfria E; Maignel J; Lezmi S; Martin V; Splevins A; Shubber S; Kalinichev M; Foster K; Picaut P; Krupp J
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29783676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.
    Tehran DA; Pirazzini M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin: application, safety, and limitations.
    Bigalke H
    Curr Top Microbiol Immunol; 2013; 364():307-17. PubMed ID: 23239359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
    Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A
    BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology.
    Caleo M; Restani L
    Toxins (Basel); 2018 Apr; 10(5):. PubMed ID: 29693600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies.
    Giordano CN; Matarasso SL; Ozog DM
    J Am Acad Dermatol; 2017 Jun; 76(6):1027-1042. PubMed ID: 28522039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.
    Pirazzini M; Rossetto O; Eleopra R; Montecucco C
    Pharmacol Rev; 2017 Apr; 69(2):200-235. PubMed ID: 28356439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System.
    Luvisetto S
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32630737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Botulinum Toxins: Challenges and Opportunities for the Future.
    Rasetti-Escargueil C; Lemichez E; Popoff MR
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered botulinum neurotoxins as new therapeutics.
    Masuyer G; Chaddock JA; Foster KA; Acharya KR
    Annu Rev Pharmacol Toxicol; 2014; 54():27-51. PubMed ID: 24016211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type B: a new injectable treatment for cervical dystonia.
    Brashear A
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity.
    Fonfria E; Elliott M; Beard M; Chaddock JA; Krupp J
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29973505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable and topical neurotoxins in dermatology: Basic science, anatomy, and therapeutic agents.
    Giordano CN; Matarasso SL; Ozog DM
    J Am Acad Dermatol; 2017 Jun; 76(6):1013-1024. PubMed ID: 28522038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.